Evidence map›Paper›PMID 39433602›Full record

ReviewAbdominal radiology (New York)2025

Benign biliary conditions with increased risk of malignant lesions.

Christopher L Welle, Rachita Khot, Sudhakar K Venkatesh, Raj Mohan Paspulati, Dhakshinamoorthy Ganeshan, Ann S Fulcher

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher L WelleMayo Clinic, Rochester, USA. welle.christopher@mayo.edu.
Rachita KhotUniversity of Virginia, Charlottesville, USA.
Sudhakar K VenkateshMayo Clinic, Rochester, USA.
Raj Mohan PaspulatiMoffitt Cancer Center, Tampa, USA.
Dhakshinamoorthy GaneshanThe University of Texas MD Anderson Cancer Center, Houston, USA.
Ann S FulcherVirginia Commonwealth University Medical Center, Richmond, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous conditions and pathologies affect the biliary system, many of which have underlying benign courses. However, these overall benign conditions can predispose the patient to malignant pathologies, often due to malignancy arising from abnormal biliary ducts (such as with cholangiocarcinoma) or due to malignancy arising from end-stage liver disease caused by the biliary condition (such as with hepatocellular carcinoma). While these malignancies can at times be obvious, some pathologies can be very difficult to detect and distinguish from the underlying benign biliary etiology. This paper discusses various benign biliary pathologies, with discussion of epidemiology, imaging features, malignant potential, and treatment considerations, with the goal of educating radiologists and referring clinicians to the risk and appearance of hepatobiliary malignancies associated with benign biliary conditions.

Indexed as

Biliary Tract DiseasesBiliary Tract NeoplasmsBile Duct NeoplasmsDiagnosis, DifferentialHumansRisk FactorsBenign biliary pathologiesBiliary systemCholangiocarcinomaHepatocellular carcinomaPrimary biliary cholangitisPrimary sclerosing cholangitis

Identifiers

PMID39433602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.